Literature DB >> 8352280

Functional studies of a germ-line polymorphism at codon 47 within the p53 gene.

E Felley-Bosco1, A Weston, H M Cawley, W P Bennett, C C Harris.   

Abstract

A rare germ-line polymorphism in codon 47 of the p53 gene replaces the wild-type proline (CCG) with a serine (TCG). Restriction analysis of 101 human samples revealed the frequency of the rare allele to be 0% (n = 69) in Caucasians and 4.7% (3/64, n = 32) among African-Americans. To investigate the consequence of this amino acid substitution, a cDNA construct (p53 mut47ser) containing the mutation was introduced into a lung adenocarcinoma cell line (Calu-6) that does not express p53. A growth suppression similar to that obtained after introduction of a wild-type p53 cDNA construct was observed, in contrast to the result obtained by introduction of p53 mut143ala. Furthermore, expression of neither p53 mut47ser nor wild-type p53 was tolerated by growing cells. In transient expression assays, both mut47ser and wild-type p53 activated the expression of a reporter gene linked to a p53 binding sequence (PG13-CAT) and inhibited the expression of the luciferase gene under the control of the Rous sarcoma virus promoter (RSVluc). In the same assay, mut143ala did not activate the expression of PG13-CAT and produced only a slight inhibitory effect on RSVluc. These findings indicate that the p53 variant with a serine at codon 47 should be considered as a rare germ-line polymorphism that does not alter the growth-suppression activity of p53.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352280      PMCID: PMC1682404     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Molecular basis for heterogeneity of the human p53 protein.

Authors:  N Harris; E Brill; O Shohat; M Prokocimer; D Wolf; N Arai; V Rotter
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

2.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

4.  Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Authors:  T Frebourg; J Kassel; K T Lam; M A Gryka; N Barbier; T I Andersen; A L Børresen; S H Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

6.  Regulation of the human hsp70 promoter by p53.

Authors:  S N Agoff; J Hou; D I Linzer; B Wu
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

7.  Allelic frequency of a p53 polymorphism in human lung cancer.

Authors:  A Weston; L S Perrin; K Forrester; R N Hoover; B F Trump; C C Harris; N E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Sep-Oct       Impact factor: 4.254

8.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

9.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  27 in total

1.  TP53 codon 72 polymorphism and glioma risk: A meta-analysis.

Authors:  Minghan Shi; Ruishan Huang; Chunying Pei; Xiuzhi Jia; Chuanlu Jiang; Huan Ren
Journal:  Oncol Lett       Date:  2011-12-12       Impact factor: 2.967

2.  TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis.

Authors:  R M Ruggeri; T M Vicchio; S Giovinazzo; R Certo; A Alibrandi; F Trimarchi; S Benvenga; M Trovato
Journal:  J Endocrinol Invest       Date:  2015-05-03       Impact factor: 4.256

3.  P53 gene polymorphisms and breast cancer risk in Arab women.

Authors:  Shafika Alawadi; Lina Ghabreau; Mervat Alsaleh; Zainab Abdulaziz; Mohamed Rafeek; Nizar Akil; Moussa Alkhalaf
Journal:  Med Oncol       Date:  2010-05-05       Impact factor: 3.064

Review 4.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 5.  Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir.

Authors:  Aga Syed Sameer
Journal:  Tumour Biol       Date:  2013-02-17

Review 6.  TP53 mutations in human cancers: origins, consequences, and clinical use.

Authors:  Magali Olivier; Monica Hollstein; Pierre Hainaut
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

7.  TP53 alterations and colorectal cancer predisposition in south Indian population: a case-control study.

Authors:  Gopi Krishna Singamsetty; Sravanthi Malempati; Srichandana Bhogadhi; Ravinder Kondreddy; Suresh Govatati; Naveen Kumar Tangudu; Sowdamani Govatati; Anil Kumar kuraganti; Manjula Bhanoori; Kondaiah Kassetty
Journal:  Tumour Biol       Date:  2013-10-26

8.  The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women.

Authors:  Abeer Al-Qasem; Mohamed Toulimat; Asma Tulbah; Naser Elkum; Taher Al-Tweigeri; Abdelilah Aboussekhra
Journal:  Oncol Lett       Date:  2012-01-24       Impact factor: 2.967

9.  Mutations and altered expression of p16INK4 in human cancer.

Authors:  A Okamoto; D J Demetrick; E A Spillare; K Hagiwara; S P Hussain; W P Bennett; K Forrester; B Gerwin; M Serrano; D H Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.

Authors:  Md Shaki Mostaid; Maizbha Uddin Ahmed; Mohammad Safiqul Islam; Muhammad Shahdaat Bin Sayeed; Abul Hasnat
Journal:  Tumour Biol       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.